Contact: Jonathan Cohen 20/20 GeneSystems, Inc. Tel. 240-453-6339 Jcohen@2020gene.com ROCKVILLE, MARYLAND – December 29, 2005 – 20/20 GeneSystems, Inc. (20/20) has been issued US Patent # 6,958,242, the second patent to cover the technology employed in the company’s BioCheck™ Powder Screening Kit. This patent has very broad claims that cover not only the specific chemistries… Continue Reading
Screen for multiple bioterror agents and rule out most false alarms
Category Archives: News
Patent Issued to 20/20 for its BioCheck technology
20/20 GeneSystems‘ patent, #6,770,485 was issued today by the US Patent and Trademark office. Entitled ‘Rapid assay, method and system for detecting biowarfare agents’, the patent covers technology used in the BioCheck Powder Screening Test Kit. Continue Reading
Introducing OneTestA new blood test for multiple cancers which can help identify the disease at an early, more treatable stage.
